Navigation Links
Bed bugs are not repelled by commercial ultrasonic frequency devices
Date:12/10/2012

Alternative means of controlling urban insect pests by using ultrasonic frequencies are available and marketed to the public. However, few of these devices have been demonstrated as being effective in repelling insect pests such as mosquitoes, cockroaches, or ants. Despite the lack of evidence for the efficacy of such devices, they continue to be sold and new versions targeting bed bugs are readily available.

However, according to a soon-to-be-published article in the Journal of Economic Entomology, commercial devices that produce ultrasound frequencies are NOT promising tools for repelling bed bugs. In "Efficacy of Commercially Available Ultrasonic Pest Repellent Devices to Affect Behavior of Bed Bugs (Hemiptera: Cimicidae)," , authors K. M. Yturralde and R. W. Hofstetter report the results of their tests of four commercially available electronic pest repellent devices designed to repel insect and mammalian pests by using sound.

The devices, which were purchased online, were used according to manufacturers' instructions. A sound arena was created for each ultrasonic device, in addition to a control arena which featured no sound. However, the authors found that there were no significant differences in the number of bed bugs observed in the control (no sound) and sound arenas, and that bed bugs were neither deterred nor attracted to the arena with the sound device.

The authors conclude that the ultrasonic devices may not have deterred or attracted bed bugs because they may not have produced the right combination of frequencies. Bed bugs are commonly exposed to frequencies made by their host species (humans) and by appliances and machines found in homes. Therefore, it may be possible that bed bugs also would exploit sounds made by their human hosts, such as breathing or snoring. Future studies of bed bug bioacoustics may be served well by using low-frequency sounds produced by host species.


'/>"/>
Contact: Richard Levine
rlevine@entsoc.org
301-731-4535
Entomological Society of America
Source:Eurekalert

Page: 1

Related biology news :

1. NIST focuses on testing standards to support lab on a chip commercialization
2. Sandia seeks commercial partners for revolutionary SpinDx medical diagnostic tool
3. Researchers take hibiscus efforts to commercialization
4. A study confirms that long commercials evoke stronger emotions
5. Kessler Foundation implements Ekso Bionics first commercial robotic exoskeleton
6. Soft Robotics: A groundbreaking new journal on engineered soft devices that Interact with Living Systems
7. Simplifying heart surgery with stretchable electronics devices
8. Medical devices powered by the ear itself
9. Tattoo-like devices for wireless pregnancy monitoring
10. NJIT professor awarded patent today for new desalination devices, more
11. Global Surgical Devices Market Growth Driven by Improving Standards of Living and Longer Life Expectancies, Research Shows
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/16/2017)...  Genos, a community for personal genetic discovery ... Laboratory Accreditation from the College of American Pathologists ... that meet stringent requirements around quality, accuracy and ... "Genos is committed to maintaining the highest ... to be receiving CAP accreditation," said Jill ...
(Date:2/13/2017)... 13, 2017  RSA Conference -- RSA, a Dell ... designed to enhance fraud detection and investigation across ... RSA Fraud & Risk Intelligence Suite. The new ... additional insights from internal and external sources as ... their customers from targeted cybercrime attacks. ...
(Date:2/10/2017)... Research and Markets has announced the addition ... and Commercial Aspects" to their offering. ... Biomarkers play an ... for selection of treatment as well for monitoring the results. ... in modern medicine. Biochip/microarray technologies and next generation sequencing are ...
Breaking Biology News(10 mins):
(Date:3/23/2017)... Colo. , March 23, 2017  GlobeImmune, Inc. ... agreement for the sale of 12,835,490 shares of its ... NantWorks  ecosystem of companies. In connection with the sale of ... $100,000 in cash and issue to GlobeImmune 200,000 shares, ... stock. "We are pleased to enter ...
(Date:3/23/2017)... New York , March 23, 2017 ... blood plasma products and derivatives market is fragmented due to the presence ... players, such as Proliant, Thermo Fisher , and Sigma-Aldrich, compete ... leader, these three companies, collectively, held more than 76% of this ... ...
(Date:3/22/2017)... (PRWEB) , ... March 22, 2017 , ... ... up human tissue regeneration from small lab samples to full-size tissues, bones, even ... to establish a vascular system that delivers blood deep into the developing tissue. ...
(Date:3/22/2017)... 2017   iSpecimen ®, the marketplace ... Pathology Service (DPS), a full-service anatomic pathology reference ... United States , has joined a program offered ... (DHIN) to make human biospecimens and associated data ... program, announced in 2015 as a collaboration between iSpecimen ...
Breaking Biology Technology: